user-generated· adoption
Wegovy pill causes 15% increase in UK obesity drug prescriptions by 2…
The introduction of the oral Wegovy pill will accelerate the adoption of GLP-1 receptor agonist drugs in the UK, leading to a 15% year-over-year increase in total obesity-related prescriptions by the end of 2026. This growth will be fueled by patient preference for oral medications and expanded access via private pharmacies.
adoption · Prediction Market
- Implied probability (Yes)
- 68%
- Closes
- 2026-12-31
More adoption markets
- OpenAI Codex mobile usage exceeds desktop by Q1 2027 — 72% Yes
- OpenAI Codex mobile usage surpasses desktop within 6 months — 70% Yes
- PGA Tour Shop app downloads increase 25% YoY in 2026 — 68% Yes
- Bluesky's AT Protocol gains adoption by 3 major third-party apps by Q1 2027 — 55% Yes
- iOS 27 public release sees 20% adoption within first 6 weeks — 60% Yes
- Animal rights NGOs expand operations in Uganda by 2027 — 75% Yes
- Passive ETF inflows into SpaceX exceed $1.5 billion by October 2026 — 55% Yes
- Anthropic's enterprise AI share surpasses 30% by Q4 2026 — 75% Yes
Loading…